Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15473-15473
Open Access | Times Cited: 47
Metabolic-Dysfunction Associated Steatotic Liver Disease -Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Ideal Treatments
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
(2023)
Open Access | Times Cited: 23
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 450-450
Open Access | Times Cited: 7
Oxidative Stress and Its Biomarkers in Cardiovascular Diseases
Julija Valaitienė, Agnė Laučytė-Cibulskienė
Artery Research (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome
Kevin Bryan Lo, Karim Iskarous, Rajiv Sankaranarayanan
Cardiology Clinics (2025)
Closed Access
EASIX (endothelial activation and stress index) predicts mortality in patients with coronary artery disease
Daniel Finke, Hauke Hund, Norbert Frey, et al.
Clinical Research in Cardiology (2024)
Open Access | Times Cited: 4
Innovative Treatments to Counteract Endothelial Dysfunction in Chronic Kidney Disease Patients
Giulia Marrone, Kevin Cornali, Manuela Di Lauro, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1085-1085
Open Access | Times Cited: 3
A Significance of Endothelial Dysfunction in Long COVID-19 for The Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
(2024)
Open Access | Times Cited: 2
The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 965-965
Open Access | Times Cited: 1
Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease
Matthieu Soulié, Yannick Stéphan, Manon Durand, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A Possible Therapeutic Application of The Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Significance of Inhibition of Urate Transporter 1 and Non-inhibition of Other Urate Transporters for Such Diseases
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top